Annual CAPEX
$2.31 M
+$721.00 K+45.35%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual capital expenditures is $2.31 million, with the most recent change of +$721.00 thousand (+45.35%) on December 31, 2023.
- During the last 3 years, HBIO annual CAPEX has risen by +$909.00 thousand (+64.84%).
- HBIO annual CAPEX is now -23.25% below its all-time high of $3.01 million, reached on December 31, 2004.
Performance
HBIO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$1.11 M
+$145.00 K+15.01%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly capital expenditures is $1.11 million, with the most recent change of +$145.00 thousand (+15.01%) on September 30, 2024.
- Over the past year, HBIO quarterly CAPEX has increased by +$710.00 thousand (+177.06%).
- HBIO quarterly CAPEX is now -26.47% below its all-time high of $1.51 million, reached on June 30, 2006.
Performance
HBIO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$3.86 M
+$710.00 K+22.55%
September 30, 2024
Summary
- As of February 12, 2025, HBIO TTM capital expenditures is $3.86 million, with the most recent change of +$710.00 thousand (+22.55%) on September 30, 2024.
- Over the past year, HBIO TTM CAPEX has increased by +$2.37 million (+159.80%).
- HBIO TTM CAPEX is now at all-time high.
Performance
HBIO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
HBIO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.4% | +177.1% | +159.8% |
| 3 y3 years | +64.8% | +131.5% | +196.5% |
| 5 y5 years | +134.4% | +213.0% | +217.3% |
HBIO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.8% | at high | +396.0% | at high | +187.3% |
| 5 y | 5-year | at high | +90.0% | at high | +439.3% | at high | +217.3% |
| alltime | all time | -23.3% | +595.0% | -26.5% | +520.8% | at high | +1002.3% |
Harvard Bioscience CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.11 M(+15.0%) | $3.86 M(+22.6%) |
| Jun 2024 | - | $966.00 K(+34.2%) | $3.15 M(+12.1%) |
| Mar 2024 | - | $720.00 K(-32.1%) | $2.81 M(+21.5%) |
| Dec 2023 | $2.31 M(+45.3%) | $1.06 M(+164.6%) | $2.31 M(+55.6%) |
| Sep 2023 | - | $401.00 K(-35.8%) | $1.49 M(-2.7%) |
| Jun 2023 | - | $625.00 K(+179.0%) | $1.53 M(+13.6%) |
| Mar 2023 | - | $224.00 K(-4.7%) | $1.34 M(-15.5%) |
| Dec 2022 | $1.59 M(+18.2%) | $235.00 K(-46.8%) | $1.59 M(-7.2%) |
| Sep 2022 | - | $442.00 K(0.0%) | $1.71 M(-2.2%) |
| Jun 2022 | - | $442.00 K(-6.2%) | $1.75 M(+15.6%) |
| Mar 2022 | - | $471.00 K(+31.6%) | $1.51 M(+12.6%) |
| Dec 2021 | $1.34 M(-4.1%) | $358.00 K(-25.4%) | $1.34 M(+3.4%) |
| Sep 2021 | - | $480.00 K(+133.0%) | $1.30 M(-6.1%) |
| Jun 2021 | - | $206.00 K(-31.6%) | $1.39 M(-5.3%) |
| Mar 2021 | - | $301.00 K(-4.1%) | $1.46 M(+4.3%) |
| Dec 2020 | $1.40 M(+15.3%) | $314.00 K(-44.3%) | $1.40 M(-8.1%) |
| Sep 2020 | - | $564.00 K(+99.3%) | $1.53 M(+15.9%) |
| Jun 2020 | - | $283.00 K(+17.4%) | $1.32 M(+0.2%) |
| Mar 2020 | - | $241.00 K(-45.0%) | $1.31 M(+8.1%) |
| Dec 2019 | $1.22 M(+23.3%) | $438.00 K(+23.4%) | $1.22 M(+43.2%) |
| Sep 2019 | - | $355.00 K(+26.8%) | $849.00 K(+13.0%) |
| Jun 2019 | - | $280.00 K(+95.8%) | $751.00 K(+20.5%) |
| Mar 2019 | - | $143.00 K(+101.4%) | $623.00 K(-36.8%) |
| Dec 2018 | $986.00 K(+6.1%) | $71.00 K(-72.4%) | $986.00 K(-12.6%) |
| Sep 2018 | - | $257.00 K(+69.1%) | $1.13 M(+1.5%) |
| Jun 2018 | - | $152.00 K(-70.0%) | $1.11 M(-8.0%) |
| Mar 2018 | - | $506.00 K(+137.6%) | $1.21 M(+29.9%) |
| Dec 2017 | $929.00 K(-37.2%) | $213.00 K(-11.3%) | $929.00 K(-25.1%) |
| Sep 2017 | - | $240.00 K(-3.2%) | $1.24 M(-19.6%) |
| Jun 2017 | - | $248.00 K(+8.8%) | $1.54 M(+2.7%) |
| Mar 2017 | - | $228.00 K(-56.6%) | $1.50 M(+1.6%) |
| Dec 2016 | $1.48 M(-50.3%) | $525.00 K(-3.1%) | $1.48 M(-9.5%) |
| Sep 2016 | - | $542.00 K(+161.8%) | $1.63 M(-6.6%) |
| Jun 2016 | - | $207.00 K(+1.0%) | $1.75 M(-18.2%) |
| Mar 2016 | - | $205.00 K(-69.9%) | $2.14 M(-28.2%) |
| Dec 2015 | $2.98 M(+48.5%) | $680.00 K(+3.3%) | $2.98 M(-3.3%) |
| Sep 2015 | - | $658.00 K(+10.4%) | $3.08 M(+6.1%) |
| Jun 2015 | - | $596.00 K(-42.9%) | $2.90 M(+4.8%) |
| Mar 2015 | - | $1.04 M(+33.7%) | $2.77 M(+38.0%) |
| Dec 2014 | $2.00 M(+19.4%) | $781.00 K(+62.7%) | $2.00 M(+14.1%) |
| Sep 2014 | - | $480.00 K(+3.9%) | $1.76 M(-1.3%) |
| Jun 2014 | - | $462.00 K(+63.8%) | $1.78 M(+10.8%) |
| Mar 2014 | - | $282.00 K(-47.1%) | $1.61 M(-4.3%) |
| Dec 2013 | $1.68 M(-8.3%) | $533.00 K(+5.8%) | $1.68 M(-8.1%) |
| Sep 2013 | - | $504.00 K(+75.0%) | $1.83 M(-2.0%) |
| Jun 2013 | - | $288.00 K(-18.6%) | $1.86 M(-1.3%) |
| Mar 2013 | - | $354.00 K(-47.9%) | $1.89 M(+3.1%) |
| Dec 2012 | $1.83 M | $680.00 K(+25.7%) | $1.83 M(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $541.00 K(+72.8%) | $1.76 M(+17.0%) |
| Jun 2012 | - | $313.00 K(+5.4%) | $1.50 M(-6.8%) |
| Mar 2012 | - | $297.00 K(-51.0%) | $1.61 M(-8.4%) |
| Dec 2011 | $1.76 M(+39.3%) | $606.00 K(+111.9%) | $1.76 M(-2.3%) |
| Sep 2011 | - | $286.00 K(-32.2%) | $1.80 M(+6.0%) |
| Jun 2011 | - | $422.00 K(-5.0%) | $1.70 M(+13.0%) |
| Mar 2011 | - | $444.00 K(-31.4%) | $1.50 M(+19.0%) |
| Dec 2010 | $1.26 M(-8.3%) | $647.00 K(+251.6%) | $1.26 M(+7.8%) |
| Sep 2010 | - | $184.00 K(-18.9%) | $1.17 M(-6.6%) |
| Jun 2010 | - | $227.00 K(+11.3%) | $1.25 M(-2.1%) |
| Mar 2010 | - | $204.00 K(-63.3%) | $1.28 M(-6.9%) |
| Dec 2009 | $1.38 M(+5.2%) | $556.00 K(+108.2%) | $1.38 M(+98.0%) |
| Sep 2009 | - | $267.00 K(+5.1%) | $695.00 K(-27.2%) |
| Jun 2009 | - | $254.00 K(-15.1%) | $955.00 K(-26.0%) |
| Mar 2009 | - | $299.00 K(-339.2%) | $1.29 M(-1.3%) |
| Dec 2008 | $1.31 M(-9.9%) | -$125.00 K(-123.7%) | $1.31 M(-20.1%) |
| Sep 2008 | - | $527.00 K(-10.7%) | $1.64 M(+7.8%) |
| Jun 2008 | - | $590.00 K(+86.7%) | $1.52 M(+23.9%) |
| Mar 2008 | - | $316.00 K(+54.1%) | $1.23 M(-15.5%) |
| Dec 2007 | $1.45 M(-39.1%) | $205.00 K(-49.9%) | $1.45 M(-33.8%) |
| Sep 2007 | - | $409.00 K(+37.7%) | $2.19 M(+44.3%) |
| Jun 2007 | - | $297.00 K(-45.1%) | $1.52 M(-44.4%) |
| Mar 2007 | - | $541.00 K(-42.8%) | $2.73 M(+14.5%) |
| Dec 2006 | $2.39 M(+116.9%) | $945.00 K(-458.0%) | $2.39 M(+57.8%) |
| Sep 2006 | - | -$264.00 K(-117.5%) | $1.51 M(-27.0%) |
| Jun 2006 | - | $1.51 M(+678.9%) | $2.07 M(+123.5%) |
| Mar 2006 | - | $194.00 K(+173.2%) | $927.00 K(-15.7%) |
| Dec 2005 | $1.10 M(-63.5%) | $71.00 K(-76.0%) | $1.10 M(-47.2%) |
| Sep 2005 | - | $296.00 K(-19.1%) | $2.08 M(-23.4%) |
| Jun 2005 | - | $366.00 K(-0.3%) | $2.72 M(-13.2%) |
| Mar 2005 | - | $367.00 K(-65.2%) | $3.13 M(+4.1%) |
| Dec 2004 | $3.01 M(+123.2%) | $1.06 M(+13.3%) | $3.01 M(+29.8%) |
| Sep 2004 | - | $932.00 K(+19.5%) | $2.32 M(+24.1%) |
| Jun 2004 | - | $780.00 K(+221.0%) | $1.87 M(+47.3%) |
| Mar 2004 | - | $243.00 K(-33.2%) | $1.27 M(-5.9%) |
| Dec 2003 | $1.35 M(+3.2%) | $364.00 K(-24.5%) | $1.35 M(-2.5%) |
| Sep 2003 | - | $482.00 K(+167.8%) | $1.38 M(+22.1%) |
| Jun 2003 | - | $180.00 K(-44.3%) | $1.13 M(-12.0%) |
| Mar 2003 | - | $323.00 K(-18.8%) | $1.29 M(-1.5%) |
| Dec 2002 | $1.31 M(-28.9%) | $398.00 K(+71.6%) | $1.31 M(-13.0%) |
| Sep 2002 | - | $232.00 K(-30.5%) | $1.50 M(-12.3%) |
| Jun 2002 | - | $334.00 K(-2.6%) | $1.71 M(-6.5%) |
| Mar 2002 | - | $343.00 K(-42.2%) | $1.83 M(-0.4%) |
| Dec 2001 | $1.84 M(+192.1%) | $593.90 K(+34.4%) | $1.84 M(+47.7%) |
| Sep 2001 | - | $442.00 K(-2.4%) | $1.25 M(+55.0%) |
| Jun 2001 | - | $453.00 K(+29.4%) | $803.00 K(+129.4%) |
| Mar 2001 | - | $350.00 K | $350.00 K |
| Dec 2000 | $629.50 K(+89.3%) | - | - |
| Dec 1999 | $332.50 K | - | - |
FAQ
- What is Harvard Bioscience annual capital expenditures?
- What is the all time high annual CAPEX for Harvard Bioscience?
- What is Harvard Bioscience annual CAPEX year-on-year change?
- What is Harvard Bioscience quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Harvard Bioscience?
- What is Harvard Bioscience quarterly CAPEX year-on-year change?
- What is Harvard Bioscience TTM capital expenditures?
- What is the all time high TTM CAPEX for Harvard Bioscience?
- What is Harvard Bioscience TTM CAPEX year-on-year change?
What is Harvard Bioscience annual capital expenditures?
The current annual CAPEX of HBIO is $2.31 M
What is the all time high annual CAPEX for Harvard Bioscience?
Harvard Bioscience all-time high annual capital expenditures is $3.01 M
What is Harvard Bioscience annual CAPEX year-on-year change?
Over the past year, HBIO annual capital expenditures has changed by +$721.00 K (+45.35%)
What is Harvard Bioscience quarterly capital expenditures?
The current quarterly CAPEX of HBIO is $1.11 M
What is the all time high quarterly CAPEX for Harvard Bioscience?
Harvard Bioscience all-time high quarterly capital expenditures is $1.51 M
What is Harvard Bioscience quarterly CAPEX year-on-year change?
Over the past year, HBIO quarterly capital expenditures has changed by +$710.00 K (+177.06%)
What is Harvard Bioscience TTM capital expenditures?
The current TTM CAPEX of HBIO is $3.86 M
What is the all time high TTM CAPEX for Harvard Bioscience?
Harvard Bioscience all-time high TTM capital expenditures is $3.86 M
What is Harvard Bioscience TTM CAPEX year-on-year change?
Over the past year, HBIO TTM capital expenditures has changed by +$2.37 M (+159.80%)